The present data first confirm that CDA-2 treatment directly results in a growth arrest of lung tumor and an extended life span in mice indicating the potent anti-tumor activity of CDA-2 in inhibiting tumor growth in a dose-dependent manner. The gene discussed is CDA; the disease is neoplasm.